Tanvex BioPharma, Inc. announced the resignation of Ken Huang as Accounting officer, effective January 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
68.8 TWD | -2.41% |
|
+1.78% | +5.68% |
Jun. 28 | Tanvex BioPharma, Inc. Announces CFO Changes, Effective June 30, 2024 | CI |
Jun. 19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+5.68% | 347M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Announces the Resignation of Ken Huang as Accounting Officer